Anavex Life Sciences Corp. (AVXL)
4.78
-0.04
(-0.83%)
USD |
NASDAQ |
Jan 15, 11:58
Anavex Life Sciences Market Cap: 427.08M for Jan. 15, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Vanda Pharmaceuticals, Inc. | 447.07M |
| CorMedix, Inc. | 545.22M |
| Verastem, Inc. | 521.21M |
| ADMA Biologics, Inc. | 4.239B |
| Aldeyra Therapeutics, Inc. | 256.90M |
Market Cap Related Metrics
| PEG Ratio | -1.532 |
| Price to Book Value | 4.502 |
| Price | 4.78 |
| Earnings Yield | -11.38% |
| PEGY Ratio | -1.532 |